Q2 2023 Holdings
Filed 2023-08-14 | 48 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Hillevax Inc | COM | 43157M102 | $168.1M | 9,781,472 | 10.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $167.0M | 4,345,559 | 10.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $144.8M | 10,109,279 | 8.6% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $129.3M | 10,871,803 | 7.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $116.3M | 990,260 | 6.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $112.8M | 4,360,107 | 6.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $82.8M | 8,684,232 | 4.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $77.6M | 3,708,838 | 4.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $62.2M | 2,944,349 | 3.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $58.2M | 1,164,405 | 3.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $35.7M | 2,167,222 | 2.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $34.2M | 1,988,876 | 2.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $32.3M | 1,787,527 | 1.9% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $30.7M | 2,985,757 | 1.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $29.1M | 3,238,859 | 1.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $29.1M | 655,000 | 1.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $25.5M | 1,414,823 | 1.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $22.9M | 854,484 | 1.4% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $21.0M | 2,248,194 | 1.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $20.5M | 857,338 | 1.2% |
| Merus N V | COM | N5749R100 | $19.7M | 746,479 | 1.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $18.3M | 899,700 | 1.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $17.8M | 1,501,383 | 1.1% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $17.5M | 1,028,013 | 1.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $17.1M | 994,858 | 1.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $17.0M | 830,983 | 1.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $16.6M | 2,142,855 | 1.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $16.4M | 6,881,090 | 1.0% |
| Morphic Hldg Inc | COM | 61775R105 | $15.2M | 265,511 | 0.9% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $12.5M | 393,000 | 0.7% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $10.2M | 100,430 | 0.6% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $9.6M | 1,803,204 | 0.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $9.0M | 386,762 | 0.5% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $8.9M | 3,746,857 | 0.5% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $8.7M | 127,900 | 0.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $8.3M | 203,684 | 0.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.1M | 285,331 | 0.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.8M | 749,022 | 0.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $5.7M | 300,000 | 0.3% |
| Bluebird BIO Inc | COM | 09609G100 | $5.6M | 1,709,907 | 0.3% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $5.2M | 370,000 | 0.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $4.8M | 881,173 | 0.3% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $4.7M | 2,401,714 | 0.3% |
| Sutro Biopharma Inc | COM | 869367102 | $3.6M | 780,000 | 0.2% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $3.5M | 1,647,030 | 0.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.7M | 264,377 | 0.2% |
| Passage BIO Inc | COM | 702712100 | $1.7M | 1,850,000 | 0.1% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $1.0M | 500,333 | 0.1% |